GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...
A ‘green channel’ and ‘white list’ system will allow samples and data to cross between innovation hubs in Lok Ma Chau and ...
TipRanks on MSN
Ultragenyx completes BLA filing for GSDIa gene therapy
Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On December 30, 2025, Ultragenyx Pharmaceutical announced it had completed the ...
For most people, the loss of a sense such as sight is devastating, not only for intensifying vulnerability, but for ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...
A research team has developed a new model, PlantIF, that addresses one of the most pressing challenges in agriculture: the ...
With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...
Yes, celiac disease is a hereditary genetic condition. People with a first-degree relative, such as a parent, child, or sibling, have a 10% higher risk of developing celiac disease, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results